Geode Capital Management LLC Buys 25,717 Shares of Cabot Corporation $CBT

Geode Capital Management LLC boosted its stake in shares of Cabot Corporation (NYSE:CBT) by 1.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,421,934 shares of the specialty chemicals company’s stock after buying an additional 25,717 shares during the period. Geode Capital Management LLC’s holdings in Cabot were worth $106,656,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Keeley Teton Advisors LLC grew its stake in shares of Cabot by 1.0% in the first quarter. Keeley Teton Advisors LLC now owns 16,756 shares of the specialty chemicals company’s stock worth $1,393,000 after acquiring an additional 174 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in Cabot by 95.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 387 shares of the specialty chemicals company’s stock worth $29,000 after purchasing an additional 189 shares in the last quarter. Ferguson Wellman Capital Management Inc. increased its stake in Cabot by 4.2% during the 2nd quarter. Ferguson Wellman Capital Management Inc. now owns 5,000 shares of the specialty chemicals company’s stock valued at $375,000 after purchasing an additional 200 shares in the last quarter. GAMMA Investing LLC raised its holdings in Cabot by 12.3% in the second quarter. GAMMA Investing LLC now owns 1,909 shares of the specialty chemicals company’s stock worth $143,000 after buying an additional 209 shares during the last quarter. Finally, CWM LLC lifted its stake in shares of Cabot by 55.0% in the first quarter. CWM LLC now owns 600 shares of the specialty chemicals company’s stock worth $50,000 after buying an additional 213 shares in the last quarter. 93.18% of the stock is owned by institutional investors.

Cabot Price Performance

Shares of CBT opened at $58.78 on Friday. The firm has a fifty day simple moving average of $69.83 and a two-hundred day simple moving average of $74.43. The firm has a market cap of $3.13 billion, a PE ratio of 7.68 and a beta of 0.90. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $115.16.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). The firm had revenue of $899.00 million during the quarter, compared to the consensus estimate of $967.02 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%.The business’s revenue was down 10.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, equities analysts anticipate that Cabot Corporation will post 7.57 EPS for the current year.

Cabot Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Friday, November 28th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, November 28th. This represents a $1.80 annualized dividend and a dividend yield of 3.1%. Cabot’s dividend payout ratio is presently 29.95%.

Analysts Set New Price Targets

Several brokerages recently weighed in on CBT. Mizuho reduced their price target on shares of Cabot from $78.00 to $72.00 and set an “outperform” rating for the company in a research report on Monday. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. Zacks Research downgraded Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. Finally, UBS Group dropped their price objective on Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Cabot currently has a consensus rating of “Reduce” and an average price target of $74.00.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.